SELLAS Life Sciences Group, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
SELLAS Life Sciences Group, Inc. (SLS) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$47.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-19
- SELLAS Life Sciences Group, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$47.00K.
- SELLAS Life Sciences Group, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2016 was -$1.33M, a 347.21% decline from fiscal 2015.
- SELLAS Life Sciences Group, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2015 was $538.00K.
- SELLAS Life Sciences Group, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2014 was -$996.00K, a 896.80% decline from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | -$47.00K 10-K · filed 2026-03-19 |
| 2016-12-31 | -$1.33M 10-K · filed 2017-03-15 |
| 2015-12-31 | $538.00K 10-K · filed 2017-03-15 |
| 2014-12-31 | -$996.00K 10-K · filed 2017-03-15 |
| 2013-12-31 | $125.00K 10-K/A · filed 2016-04-15 |
| 2012-12-31 | $0.00 8-K · filed 2015-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |